Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000579674 | SCV000683318 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-01-15 | criteria provided, single submitter | clinical testing | This synonymous variant does not change the amino acid sequence of the BRCA1 protein. However, a different variant occurring in the same codon, c.5453A>G, results in skipping of exon 22 (BIC exon 23) and is known to be pathogenic (Clinvar variation ID: 37672), suggesting that an exonic splice enhancer may overlap with this codon (PMID 20875879). To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000985442 | SCV001133634 | uncertain significance | not provided | 2018-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000579674 | SCV001186098 | likely benign | Hereditary cancer-predisposing syndrome | 2018-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Brotman Baty Institute, |
RCV001077422 | SCV001243353 | not provided | Breast-ovarian cancer, familial, susceptibility to, 1 | no assertion provided | in vitro | ||
King Laboratory, |
RCV001171389 | SCV001251287 | benign | not specified | 2019-09-01 | no assertion criteria provided | research |